Rayzebio Inc (RYZB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | |
| Operating Expenses | 72,120 | 39,379 |
| Operating Income | -72,120 | -39,379 |
| Other Income | 3,520 | 9,935 |
| Pre-tax Income | -68,600 | -29,444 |
| Net Income Continuous | -68,600 | -29,444 |
| Net Income | $-68,600 | $-29,444 |
| EPS Basic Total Ops | -19.90 | -21.03 |
| EPS Basic Continuous Ops | -18.66 | -10.95 |
| EPS Diluted Total Ops | -19.90 | -21.03 |
| EPS Diluted Continuous Ops | -18.66 | -10.95 |
| EBITDA(a) | $-71,276 | $-37,501 |